l 365031 has been researched along with l 365260 in 2 studies
| Studies (l 365031) | Trials (l 365031) | Recent Studies (post-2010) (l 365031) | Studies (l 365260) | Trials (l 365260) | Recent Studies (post-2010) (l 365260) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 422 | 10 | 8 |
| Protein | Taxonomy | l 365031 (IC50) | l 365260 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0081 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0081 | |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.4981 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.039 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0081 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 5 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.1585 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.0079 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.044 | |
| Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | 5 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coughlan, J; Dourish, CT; Hawley, D; Iversen, SD; Kitchener, SJ; O'Neill, MF | 1 |
| Dourish, CT; Hendrie, CA; Neill, JC; Shepherd, JK | 1 |
2 other study(ies) available for l 365031 and l 365260
| Article | Year |
|---|---|
The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
Topics: Analgesia; Animals; Benzodiazepines; Benzodiazepinones; Drug Tolerance; Male; Morphine; Naloxone; Pain; Pain Measurement; Phenylurea Compounds; Rats; Rats, Inbred Strains; Reaction Time; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Mice, Inbred DBA; Phenylurea Compounds; Receptors, Cholecystokinin | 1993 |